No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer

Abstract Background Studies over the past 10 years strongly support an association between skeletal muscle mass (SMM) depletion and outcome in metastatic colorectal cancer (mCRC). Factors influencing SMM changes over time are, however, poorly studied. We analyzed the impact of SMM on overall surviva...

Full description

Bibliographic Details
Main Authors: Sami Antoun, Mohamed Amine Bayar, Valérie Dyevre, Emilie Lanoy, Cristina Smolenschi, Michel Ducreux
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Cancer
Subjects:
Muscle mass depletion
Metastatic colorectal cancer
Weight loss
Body composition
Overall survival
Chemotherapy toxicity
Online Access:http://link.springer.com/article/10.1186/s12885-019-6086-2

Internet

http://link.springer.com/article/10.1186/s12885-019-6086-2

Similar Items